GlassScriptPhysician profile
Robert Vyge
NPI 1760400881
$1,141.29
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $764 · 2020: $61.95 · 2021: $125 · 2022: $146 · 2023: $44.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $44.14 · Education: $0.79.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $44.14 |
| Education | $0.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $354.61 | 2019-2022 | |
| Amgen INC. | $152.07 | 2019 | |
| Lilly USA, LLC | $100.30 | 2019-2022 | |
| Boston Scientific Corporation | $100.03 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $99.34 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $39.66 | 2019 | |
| Merck Sharp & Dohme LLC | $37.11 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $31.35 | 2019-2022 | |
| Otsuka America Pharmaceutical, INC. | $27.27 | 2022 | |
| Pfizer INC. | $25.80 | 2019-2020 | |
| Ultragenyx Pharmaceutical INC. | $24.84 | 2023 | |
| Abbott Laboratories | $20.62 | 2022 | |
| Idorsia Pharmaceuticals US INC | $19.30 | 2023 | Quviviq |
| Daiichi Sankyo INC. | $18.85 | 2019 | |
| Ironwood Pharmaceuticals, INC | $16.93 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $15.70 | 2019 | |
| Abbvie INC. | $14.98 | 2022 | |
| Allergan, INC. | $14.40 | 2019 | |
| Janssen Pharmaceuticals, INC | $14.38 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $12.96 | 2019 | |
| Sumitomo Pharma America, INC. | $0.79 | 2023 | Gemtesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Vyge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.